DE60227763D1 - Verwendung eines natriuretischen peptids vom b-typ als prognostischer indikator bei akuten koronaren syndromen - Google Patents
Verwendung eines natriuretischen peptids vom b-typ als prognostischer indikator bei akuten koronaren syndromenInfo
- Publication number
- DE60227763D1 DE60227763D1 DE60227763T DE60227763T DE60227763D1 DE 60227763 D1 DE60227763 D1 DE 60227763D1 DE 60227763 T DE60227763 T DE 60227763T DE 60227763 T DE60227763 T DE 60227763T DE 60227763 D1 DE60227763 D1 DE 60227763D1
- Authority
- DE
- Germany
- Prior art keywords
- acute coronary
- wave
- natriuretic peptide
- coronary syndrome
- type natriuretic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6887—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids from muscle, cartilage or connective tissue
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/575—Hormones
- G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/32—Cardiovascular disorders
- G01N2800/324—Coronary artery diseases, e.g. angina pectoris, myocardial infarction
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/835,298 US7632647B2 (en) | 2001-04-13 | 2001-04-13 | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
PCT/US2002/011441 WO2002083913A1 (en) | 2001-04-13 | 2002-04-11 | Use of b-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
Publications (1)
Publication Number | Publication Date |
---|---|
DE60227763D1 true DE60227763D1 (de) | 2008-09-04 |
Family
ID=25269150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60227763T Expired - Lifetime DE60227763D1 (de) | 2001-04-13 | 2002-04-11 | Verwendung eines natriuretischen peptids vom b-typ als prognostischer indikator bei akuten koronaren syndromen |
Country Status (11)
Country | Link |
---|---|
US (3) | US7632647B2 (de) |
EP (2) | EP1983058B1 (de) |
JP (2) | JP3749225B2 (de) |
AT (1) | ATE402266T1 (de) |
AU (2) | AU2002252636B2 (de) |
CA (1) | CA2412648C (de) |
DE (1) | DE60227763D1 (de) |
DK (1) | DK1311701T3 (de) |
ES (1) | ES2310590T3 (de) |
NZ (1) | NZ523210A (de) |
WO (1) | WO2002083913A1 (de) |
Families Citing this family (134)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6627404B1 (en) * | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
US6991907B1 (en) * | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
US7632647B2 (en) | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
US20030199000A1 (en) * | 2001-08-20 | 2003-10-23 | Valkirs Gunars E. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US20030219734A1 (en) * | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
US20040176914A1 (en) * | 2001-04-13 | 2004-09-09 | Biosite Incorporated | Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential |
US7524635B2 (en) * | 2003-04-17 | 2009-04-28 | Biosite Incorporated | Methods and compositions for measuring natriuretic peptides and uses thereof |
EP1666881B1 (de) * | 2001-05-04 | 2010-02-17 | Biosite Incorporated | Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen |
US20040209307A1 (en) * | 2001-08-20 | 2004-10-21 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
JP2005522669A (ja) * | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | 卒中および脳損傷の診断マーカーおよびその使用方法 |
US20040219509A1 (en) * | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US7608406B2 (en) * | 2001-08-20 | 2009-10-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US6461828B1 (en) | 2001-09-04 | 2002-10-08 | Syn X Pharma | Conjunctive analysis of biological marker expression for diagnosing organ failure |
MXPA03004105A (es) | 2002-05-14 | 2004-10-15 | Hoffmann La Roche | Elaboracion de una prognosis en casos de enfermedad cardiaca usando una combinacion de marcadores. |
AU2003297583B2 (en) * | 2002-11-26 | 2010-01-14 | Biocon, Ltd | Modified naturetic compounds, conjugates, and uses thereof |
CA2511501A1 (en) * | 2002-12-24 | 2004-07-15 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
WO2004082639A2 (en) * | 2003-03-19 | 2004-09-30 | Baylor College Of Medicine | Detecting coronary artery disease with bnp during stress testing |
JP2006527190A (ja) * | 2003-04-17 | 2006-11-30 | サイファージェン バイオシステムズ インコーポレイテッド | ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法 |
WO2004097368A2 (en) * | 2003-04-28 | 2004-11-11 | Ciphergen Biosystems, Inc. | Improved immunoassays |
WO2004105575A2 (en) * | 2003-05-29 | 2004-12-09 | Trustee Of Darmouth College | A method for detecting cardiac ischemia via changes in b-natriuretic peptide levels |
US7632234B2 (en) * | 2003-08-29 | 2009-12-15 | Medtronic, Inc. | Implantable biosensor devices for monitoring cardiac marker molecules |
EP1673465A4 (de) * | 2003-09-29 | 2008-04-30 | Biosite Inc | Verfahren und zusammensetzungen zur sepsisdiagnose |
DE10355731A1 (de) | 2003-11-28 | 2005-06-30 | Roche Diagnostics Gmbh | Analytischer Sandwichtest zur Bestimmung von NT-proBNP |
GB0329288D0 (en) | 2003-12-18 | 2004-01-21 | Inverness Medical Switzerland | Monitoring method and apparatus |
JP2007534363A (ja) * | 2003-12-18 | 2007-11-29 | インバーネス メディカル スウィッツァーランド ゲーエムベーハー | モニタリング方法およびモニタリング装置 |
ATE403157T1 (de) * | 2004-03-15 | 2008-08-15 | Hoffmann La Roche | Verwendung des bnp-art und anp-art peptiden für das festsetzen der gefahren von herzgefäss- komplikationen als folge der volumenüberlastung |
US7223237B2 (en) * | 2004-04-22 | 2007-05-29 | Pacesetter, Inc. | Implantable biosensor and methods for monitoring cardiac health |
JP4838794B2 (ja) * | 2004-06-15 | 2011-12-14 | エフ.ホフマン−ラ ロシュ アーゲー | 心臓毒性医薬の結果として心血管合併症に罹患するリスクを診断するための心臓ホルモンの使用 |
JP2008514900A (ja) * | 2004-07-30 | 2008-05-08 | アデザ・バイオメデイカル・コーポレイシヨン | 疾病および他の状態のマーカーとしての癌胎児性フィブロネクチンならびに癌胎児性フィブロネクチンの検出のための方法 |
US20060084114A1 (en) * | 2004-10-15 | 2006-04-20 | Yeo Kiang-Tech J | Method for detecting cardiac collateral formation |
WO2006076471A2 (en) * | 2005-01-12 | 2006-07-20 | Nobex Corporation | Bnp conjugates and methods of use |
EP1691200A1 (de) * | 2005-02-14 | 2006-08-16 | F. Hoffmann-La Roche Ag | Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung |
EP1986012B1 (de) * | 2005-01-24 | 2012-06-06 | F. Hoffmann-La Roche AG | Verwendung von Bnp-typ für die Ermittlung von Herzversagen Risiken als Folge der Volumenüberlastung |
US7432107B2 (en) * | 2005-01-24 | 2008-10-07 | Roche Diagnostics Operations, Inc. | Cardiac hormones for assessing cardiovascular risk |
US7731965B2 (en) * | 2005-02-17 | 2010-06-08 | Abbott Lab | Human ring specific BNP antibodies |
US7300494B2 (en) * | 2005-02-24 | 2007-11-27 | Hamilton Sundstrand Corporation | On-board inert gas generation system with compressor surge protection |
US7769451B2 (en) | 2005-04-28 | 2010-08-03 | Medtronic, Inc. | Method and apparatus for optimizing cardiac resynchronization therapy |
EP1722232A1 (de) * | 2005-05-09 | 2006-11-15 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Diagnose oder zur Früherkennung der kardialen Dysfunktion |
US20080221033A1 (en) * | 2005-07-29 | 2008-09-11 | Koninklijke Philips Electronics N. V. | Monitoring of Cardiac Natriuretic Peptides During Diagnosis, Management, and Treatment of Cardiac Diseases |
EP1957535A1 (de) * | 2005-11-09 | 2008-08-20 | Abbott Laboratories | Humane bnp-immunspezifische antikörper |
US7939069B2 (en) | 2005-11-09 | 2011-05-10 | Abbott Laboratories | Human BNP immunospecific antibodies |
EP2005168A4 (de) * | 2006-03-09 | 2009-05-20 | Biosite Inc | Verfahren und zusammensetzung zur diagnose von krankheiten der aorta |
EP1835289A1 (de) * | 2006-03-13 | 2007-09-19 | Roche Diagnostics GmbH | Mittel und Verfahren zur Prognose kardiovaskulärer Komplikationen bei Personen mit Osteoporose |
ES2344993T3 (es) | 2006-03-24 | 2010-09-13 | F. Hoffmann-La Roche Ag | Medios y metodos para la diferenciacion de la necrosis de miocardio aguda y cronica en pacientes sintomaticos. |
JP6325022B2 (ja) * | 2006-04-04 | 2018-05-16 | シングレックス,インコーポレイテッド | トロポニンの分析のための高感度のシステムおよび方法 |
EP1845379A1 (de) * | 2006-04-13 | 2007-10-17 | F. Hoffmann-La Roche AG | Mittel und Verfahren zur Differenzierung kardialer und pulmonaler Ursachen von Atemnot |
US20080118924A1 (en) * | 2006-05-26 | 2008-05-22 | Buechler Kenneth F | Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
EP1882945A1 (de) | 2006-07-28 | 2008-01-30 | F.Hoffmann-La Roche Ag | Vorrichtungen und Verfahren zur Differentierung zwischen herz- und lungenbedingten Ursachen für akute Atemnot |
BRPI0715126B8 (pt) * | 2006-08-04 | 2021-07-27 | Medizinische Hochschule Hannover | métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15 |
EP1890154B1 (de) * | 2006-08-16 | 2012-07-04 | F. Hoffmann-La Roche AG | Herztroponin als Indikator für fortgeschrittene Koronararterienerkrankung und deren Komplikationen |
EP1890153A1 (de) * | 2006-08-16 | 2008-02-20 | F. Hoffman-la Roche AG | Herztroponin als Indikator für fortgeschrittene Koronararterienerkrankung |
US20080050749A1 (en) * | 2006-08-17 | 2008-02-28 | Ildiko Amann-Zalan | Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents |
CN101611318B (zh) * | 2006-09-07 | 2015-03-04 | 奥塔哥创新有限公司 | 生物标记物 |
US20080064045A1 (en) * | 2006-09-07 | 2008-03-13 | Huaiqin Wu | Biomarker fragments for the detection of human BNP |
ES2334155T3 (es) | 2006-09-15 | 2010-03-05 | F. Hoffmann-La Roche Ag | Marcadores bioquimicos para el embolismo pulmonar agudo. |
EP1901073A1 (de) | 2006-09-18 | 2008-03-19 | Roche Diagnostics GmbH | Natriuretische Peptide zur Diagnose von Herzkomplikationen infolge von Koronarkatheterisierung |
EP2500723B1 (de) | 2006-11-14 | 2015-07-08 | Alere San Diego, Inc. | Verfahren zur Überwachung und Risikoabschätzung des Herz-Nieren-Syndroms |
US8524462B2 (en) * | 2006-11-14 | 2013-09-03 | Alere San Diego, Inc. | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
WO2008061978A2 (en) * | 2006-11-21 | 2008-05-29 | Roche Diagnostics Gmbh | Means and methods for optimization of diagnostic and therapeutic approaches in chronic artery disease based on the detection of troponin t and nt-probnp |
EP1925943A1 (de) * | 2006-11-21 | 2008-05-28 | F. Hoffman-la Roche AG | Vorrichtungen und Verfahren zur Optimierung von diagnostischen and therapeutischen Ansätzen für chronische Arterienerkrankungen basierend auf dem Nachweis von Troponin T und NT-proBNP. |
CA2669863A1 (en) * | 2006-12-22 | 2008-07-03 | Abbott Laboratories | Cardiovascular autoimmune disease panel and methods of using same |
EP2115477B1 (de) | 2007-01-25 | 2015-06-24 | Roche Diagnostics GmbH | Verwendung von igfbp-7 bei der beurteilung von herzversagen |
EP2101178A1 (de) * | 2008-03-12 | 2009-09-16 | BRAHMS Aktiengesellschaft | Verwendung von Procalcitonin zur Prognose folgender akuter Koronarsyndromen |
JP5059943B2 (ja) | 2007-08-03 | 2012-10-31 | ベー.エル.アー.ハー.エム.エス ゲゼルシャフト ミット ベシュレンクテル ハフツング | リスク階層化におけるプロカルシトニン(PCT)の使用、及び原発性の非感染性疾患を有する患者の予後診断を実施するためのinvitro方法 |
EP2031397A1 (de) | 2007-08-30 | 2009-03-04 | F. Hoffmann-La Roche AG | Surfactantproteine B und D bei der Unterscheidung der Ursachen für Atemnot |
WO2009047285A1 (en) | 2007-10-10 | 2009-04-16 | Roche Diagnostics Gmbh | Natriuretic peptide/troponin ratio for the assessment of preexisting myocardial dysfunction in patients with acute coronary syndrome |
EP2103943A1 (de) | 2008-03-20 | 2009-09-23 | F. Hoffman-la Roche AG | GDF-15 zur Beurteilung eines kardiovaskulären Risikos hinsichtlich Verabreichung von Entzündungshemmern |
WO2009141374A1 (en) | 2008-05-21 | 2009-11-26 | F. Hoffmann-La Roche Ag | L-fabp, natriuretic peptides and cardiac troponin in individuals in need for a cardiac therapy |
EP2133696A1 (de) | 2008-06-10 | 2009-12-16 | Eberhardt Spanuth | Sehr geringe Konzentrationen von Troponin I oder T zur Beurteilung eines kardiovaskulären Risikos hinsichtlich der Verabreichung von Entzündungshemmern |
JP2011523072A (ja) * | 2008-06-13 | 2011-08-04 | エフ.ホフマン−ラ ロシュ アーゲー | 1型糖尿病を有する患者の合併症の評価 |
EP2318844A1 (de) * | 2008-07-14 | 2011-05-11 | Roche Diagnostics GmbH | Multimarkerpanel zur diagnose, überwachung und auswahl der therapie für patienten mit herzinsuffizienz |
WO2010010153A1 (en) | 2008-07-23 | 2010-01-28 | F. Hoffmann-La Roche Ag | Identification of subjects being susceptible to anti-angiogenesis therapy |
WO2010017972A1 (en) | 2008-08-13 | 2010-02-18 | Roche Diagnostics Gmbh | D-dimer, troponin, nt-probnp for pulmonary embolism |
KR101758667B1 (ko) | 2009-04-29 | 2017-07-18 | 아카데미쉬 메디쉬 센트륨 | 심부전 또는 심부전 위험성을 방지, 예방 및/또는 측정하기 위한 수단 및 방법 |
RU2548710C2 (ru) | 2009-09-17 | 2015-04-20 | Ф.Хоффманн-Ля Рош Аг | Мультимаркерная панель для гипертрофии левого желудочка |
JP5728488B2 (ja) * | 2009-11-13 | 2015-06-03 | ビージー メディシン, インコーポレイテッド | 心筋梗塞のリスクファクターおよび予測 |
EP3246708A3 (de) | 2009-12-18 | 2018-01-03 | Roche Diagnostics GmbH | Troponins zur prognose von nierenausfall bei herzchirurgiepatienten |
CZ302379B6 (cs) * | 2009-12-22 | 2011-04-20 | Ústav informatiky AV CR, v.v.i. Centrum biomedicínské informatiky | Zpusob stanovení prognózy pacientu s primárním infarktem myokardu a oligonukleotidový cip pro toto stanovení |
US9506909B2 (en) | 2010-02-12 | 2016-11-29 | Synlab Medizinisches Versorgungszentrum Heidelberg Gmbh | Homoarginine as a biomarker for the risk of mortality |
EP2388594A1 (de) | 2010-05-17 | 2011-11-23 | Roche Diagnostics GmbH | Mittel auf GDF-15-Basis sowie Verfahren zur Überlebens- und Genesungsvorhersage bei akuter Entzündung |
WO2012020045A1 (en) | 2010-08-10 | 2012-02-16 | Roche Diagnostics Gmbh | Method for selecting patients with stable coronary artery disease for pci or medical treatment |
EP2367006A1 (de) | 2010-08-24 | 2011-09-21 | Roche Diagnostics GmbH | Mittel und Verfahren auf PLGF-Basis zur Diagnose kardialer Ursachen bei akuten Entzündungen |
CN105044349B (zh) | 2010-08-26 | 2018-04-06 | 弗·哈夫曼-拉罗切有限公司 | 生物标志物在评估从动脉高血压向心力衰竭的早期转变中的用途 |
EP2439535A1 (de) | 2010-10-07 | 2012-04-11 | F. Hoffmann-La Roche AG | Diagnose von Herzerkrankungen im Zusammenhang mit Diabetes und GDF-15 und Troponin als Prädiktor für die Entwicklung von Diabetes mellitus Typ 2 |
EP2447720A1 (de) | 2010-10-26 | 2012-05-02 | Roche Diagnostics GmbH | sFlt1 und Lungenkomplikationen |
EP2383579A1 (de) | 2010-12-17 | 2011-11-02 | F. Hoffmann-La Roche AG | sFlt-1, Kardiotroponine und natriuretische Peptide beim Nachweis einer Therapie mit HER-2-Inhibitoren |
CN102103143B (zh) * | 2011-02-24 | 2013-09-25 | 南京基蛋生物科技有限公司 | 一种双指标检测用胶体金试纸条及其制备方法 |
EP2385373A1 (de) | 2011-07-01 | 2011-11-09 | F. Hoffmann-La Roche AG | Natriuretische Peptide bei der Schwangerschaft |
EP2581040A1 (de) | 2011-10-10 | 2013-04-17 | Roche Diagnostics GmbH | TNT-basiertes Herzhypertrophierisiko im Zusammenhang mit physiologischem Training und Führung in Athleten |
WO2013057135A1 (en) | 2011-10-17 | 2013-04-25 | Roche Diagnostics Gmbh | Troponin and bnp based diagnosis of risk patients and cause of stroke |
ES2656082T3 (es) | 2011-12-01 | 2018-02-23 | F. Hoffmann-La Roche Ag | NT-proANP y NT-proBNP para el diagnóstico del accidente cerebrovascular |
ES2538226T3 (es) | 2012-01-26 | 2015-06-18 | F. Hoffmann-La Roche Ag | Método para la diferenciación de la insuficiencia cardiaca anterógrada y retrógrada |
EP2650684A1 (de) | 2012-04-10 | 2013-10-16 | Roche Diagniostics GmbH | Diagnose auf Pro-SP-B und NT-proBNP bei Patienten mit Lungenentzündung |
EP2615459A1 (de) | 2012-04-27 | 2013-07-17 | Roche Diagniostics GmbH | Verfahren zur Diagnose von Distalbronchoalveolargewebeschäden in Asthma durch Erkennen von proSP-B |
EP2600155A1 (de) | 2012-06-18 | 2013-06-05 | Roche Diagniostics GmbH | sFlt-1-basierte Diagnose und Überwachung von Schlaganfallpatienten |
EP2597467A1 (de) | 2012-06-26 | 2013-05-29 | Roche Diagniostics GmbH | Mittel und Verfahren zur proSP-B-basierten Diagnose von Lungenstauung bei Patienten mit akutem Koronarsyndrom |
EP2597466A1 (de) | 2012-06-26 | 2013-05-29 | Roche Diagniostics GmbH | Mittel und Verfahren zur proSP-B-basierten Diagnose von Alveolenbeschädigung bei Patienten mit pulmonaler Hypertonie |
WO2014009418A1 (en) | 2012-07-10 | 2014-01-16 | Roche Diagnostics Gmbh | TnT, NTproBNP, sFlt-1 for CURB65 IN PNEUMONIA |
JP6247302B2 (ja) | 2012-09-12 | 2017-12-13 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | 異常な短縮率(fractionalshortening)を持つ患者の同定 |
US20140273273A1 (en) | 2012-11-01 | 2014-09-18 | Christie Mitchell Ballantyne | Biomarkers to improve prediction of heart failure risk |
CN108120837B (zh) | 2012-11-09 | 2021-06-22 | 霍夫曼-拉罗奇有限公司 | 阵发性心房纤颤的基于TnT的诊断 |
EP2730923A1 (de) | 2012-11-09 | 2014-05-14 | Roche Diagniostics GmbH | NTproBNP- und cTnT-basierte Therapieanleitung bei Herzversagen |
WO2014086833A1 (en) | 2012-12-04 | 2014-06-12 | Roche Diagnostics Gmbh | Biomarkers in the selection of therapy of heart failure |
EP2866033A1 (de) | 2013-10-23 | 2015-04-29 | Roche Diagniostics GmbH | Differenzialdiagnose von akuter Atemnot auf Basis von c-terminiertem proSP-B, KL-6 und BNP-Peptiden |
AU2014343709B2 (en) | 2013-11-04 | 2020-11-19 | The Regents Of The University Of Michigan | Biomarkers and methods for progression prediction for chronic kidney disease |
CN106461636A (zh) * | 2014-01-10 | 2017-02-22 | 重症监护诊断股份有限公司 | 用于测定心力衰竭风险的方法和系统 |
EP3470848A3 (de) | 2014-01-28 | 2019-05-22 | Roche Diagnostics GmbH | Biomarker zur risikobewertung und behandlungsüberwachung bei patienten mit herzinsuffizienz durch natriuretische peptide |
EP2916134B1 (de) | 2014-03-05 | 2017-08-16 | Roche Diagnostics GmbH | Verwendung von Seprase zur Differenzialdiagnose von akuter Atemnot |
ES2676553T3 (es) | 2014-03-26 | 2018-07-20 | F. Hoffmann-La Roche Ag | IGFBP7 para el diagnóstico de la disfunción diastólica |
AU2014407088B2 (en) | 2014-09-26 | 2021-09-23 | Somalogic Operating Co., Inc. | Cardiovascular risk event prediction and uses thereof |
EP3411721A1 (de) | 2016-02-04 | 2018-12-12 | Metanomics GmbH | Mittel und verfahren zur differenzierung zwischen herzinsuffizienz und lungenerkrankung bei einer person |
ES2817087T3 (es) | 2016-08-04 | 2021-04-06 | Hoffmann La Roche | ESM-1 (endocan) circulante en la evaluación de la fibrilación auricular |
WO2018069487A1 (en) | 2016-10-14 | 2018-04-19 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and kits for predicting the risk of loss of renal function in patients with type 2 diabetes |
WO2018127372A1 (en) | 2016-12-13 | 2018-07-12 | Witteman Johanna Cornelia Maria | Detection of transient troponin peaks for diagnosis of subjects at high risk of cardiovascular disease |
EP3360570A1 (de) | 2017-02-13 | 2018-08-15 | Roche Diagnostics GmbH | Monoklonale antikörper für nt-probnp punktmutationen |
JP6985517B2 (ja) * | 2017-09-30 | 2021-12-22 | アルフレッド ヘルス | 予後予測方法 |
BR112021001798A2 (pt) | 2018-07-31 | 2021-04-27 | F. Hoffmann-La Roche Ag | métodos para avaliar a fibrilação atrial, para diagnosticar insuficiência cardíaca, para auxiliar na avaliação da fibrilação atrial, para prever o risco de acidente vascular cerebral e para aprimorar a precisão da previsão, usos e kit |
CN112888948A (zh) | 2018-08-10 | 2021-06-01 | 豪夫迈·罗氏有限公司 | 用于评定Afib相关性脑卒中的CES-2(羧酸酯酶-2) |
BR112021002725A2 (pt) | 2018-08-16 | 2021-07-20 | F. Hoffmann-La Roche Ag | métodos para avaliar a fibrilação atrial, para prever o risco de acidente vascular cerebral, para avaliar a eficácia de uma terapia, para identificar um paciente, para monitorar a terapia de anticoagulação e para auxiliar na avaliação da fibrilação atrial, método implementado por computador, kit e uso in vitro |
CN113260863A (zh) | 2018-08-17 | 2021-08-13 | 豪夫迈·罗氏有限公司 | 用于心房纤颤的评价中的循环bmp10 (骨形态发生蛋白10) |
KR20210047304A (ko) | 2018-08-22 | 2021-04-29 | 에프. 호프만-라 로슈 아게 | 심방 세동 평가에서 순환 spon-1 (스폰딘-1) |
WO2020039085A1 (en) | 2018-08-24 | 2020-02-27 | Roche Diagnostics Gmbh | Circulating fgfbp-1 (fibroblast growth factor-binding protein 1) in the assessment of atrial fibrillation and for the prediction of stroke |
WO2020064995A1 (en) | 2018-09-28 | 2020-04-02 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Use of biomarkers representing cardiac, vascular and inflammatory pathways for the prediction of acute kidney injury in patients with type 2 diabetes |
US11446009B2 (en) | 2018-12-11 | 2022-09-20 | Eko.Ai Pte. Ltd. | Clinical workflow to diagnose heart disease based on cardiac biomarker measurements and AI recognition of 2D and doppler modality echocardiogram images |
US11931207B2 (en) | 2018-12-11 | 2024-03-19 | Eko.Ai Pte. Ltd. | Artificial intelligence (AI) recognition of echocardiogram images to enhance a mobile ultrasound device |
JP2022534034A (ja) | 2019-05-23 | 2022-07-27 | エフ.ホフマン-ラ ロシュ アーゲー | HFpEFのためのIGFBP7の比 |
CN115190886A (zh) | 2020-02-20 | 2022-10-14 | 马斯特里赫特大学 | 循环bmp10(骨形态发生蛋白10)的检测方法 |
US11419917B2 (en) | 2020-04-07 | 2022-08-23 | Drora Shevy | Treatment for SARS-CoV-2 and other coronaviruses |
CN116235056A (zh) | 2020-09-30 | 2023-06-06 | 豪夫迈·罗氏有限公司 | 心房颤动评定中的循环总NT-proBNP(糖基化和未糖基化NT-proBNP)及其与NT-proBNP(未糖基化NT-proBNP)的比率 |
CN112710852B (zh) * | 2021-03-26 | 2021-08-03 | 上海美迪西生物医药股份有限公司 | 一种gnp多肽的检测试剂盒及检测方法 |
WO2023175152A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Troponin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
WO2023175176A1 (en) | 2022-03-18 | 2023-09-21 | Roche Diagnostics Gmbh | Cmybpc marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction |
Family Cites Families (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5292636A (en) * | 1986-03-31 | 1994-03-08 | T Cell Diagnostics, Inc. | Therapeutic and diagnostic methods using soluble T cell surface molecules |
US5382522A (en) * | 1987-07-21 | 1995-01-17 | International Immunoassay Laboratories, Inc. | Immunoassay for creatine kinase-MB and creatine kinase-BB isoforms and reagents |
US5382515A (en) * | 1987-07-21 | 1995-01-17 | International Immunoassay Laboratories, Inc. | Creative kinase-MB immunoassay for myocardial infarction and reagents |
US4900662A (en) * | 1987-07-21 | 1990-02-13 | International Immunoassay Laboratories, Inc. | CK-MM myocardial infarction immunoassay |
US5453359A (en) * | 1988-06-13 | 1995-09-26 | American Biogenetic Sciences, Inc. | Immunoassay and kit for in vitro detection of soluble DesAABB fibrin polymers |
US5206140A (en) | 1988-06-24 | 1993-04-27 | Research Corporation Technologies, Inc. | Assay for soluble crosslinked fibrin polymers |
US5422393A (en) | 1988-07-11 | 1995-06-06 | Naturon Pharmaceutical Corporation | Natriuretic hormone |
US5028535A (en) | 1989-01-10 | 1991-07-02 | Biosite Diagnostics, Inc. | Threshold ligand-receptor assay |
US5939272A (en) | 1989-01-10 | 1999-08-17 | Biosite Diagnostics Incorporated | Non-competitive threshold ligand-receptor assays |
DE69032598T2 (de) | 1989-06-23 | 1999-03-11 | Genentech Inc | Zusammensetzungen und methoden zur synthese des b-rezeptors für das natriuretische protein und verwendungsmethoden |
US5580722A (en) | 1989-07-18 | 1996-12-03 | Oncogene Science, Inc. | Methods of determining chemicals that modulate transcriptionally expression of genes associated with cardiovascular disease |
SE8904407L (sv) | 1989-12-29 | 1991-06-30 | Qingpingfeng | Medikament foer behandling av hjaertsvikt |
US5922615A (en) | 1990-03-12 | 1999-07-13 | Biosite Diagnostics Incorporated | Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network |
WO1992005282A1 (en) | 1990-09-14 | 1992-04-02 | Biosite Diagnostics, Inc. | Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays |
US5604105B1 (en) | 1990-10-12 | 1999-08-24 | Spectral Diagnostics Inc | Method and device for diagnosingand distinguishing chest pain in early onset thereof |
CA2027434C (en) * | 1990-10-12 | 1999-01-05 | George Jackowski | Diagnostic kit for diagnosing and distinguishing chest pain in early onset thereof |
US5710008B1 (en) * | 1990-10-12 | 1999-09-07 | Spectral Diagnostics Inc | Method and device for diagnosing and distinguishing chest pain in early onset thereof |
US5955377A (en) | 1991-02-11 | 1999-09-21 | Biostar, Inc. | Methods and kits for the amplification of thin film based assays |
ATE177841T1 (de) | 1991-04-10 | 1999-04-15 | Biosite Diagnostics Inc | ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung |
AU1911592A (en) | 1991-04-10 | 1992-11-17 | Biosite Diagnostics Incorporated | Novel conjugates and assays for simultaneous detection of multiple ligands |
US6143576A (en) | 1992-05-21 | 2000-11-07 | Biosite Diagnostics, Inc. | Non-porous diagnostic devices for the controlled movement of reagents |
US6019944A (en) | 1992-05-21 | 2000-02-01 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membranes |
GB9211686D0 (en) | 1992-06-03 | 1992-07-15 | Medisinsk Innovation A S | Chemical compounds |
US5494829A (en) | 1992-07-31 | 1996-02-27 | Biostar, Inc. | Devices and methods for detection of an analyte based upon light interference |
US6147688A (en) | 1993-06-28 | 2000-11-14 | Athena Design Systems, Inc. | Method and apparatus for defining and selectively repeating unit image cells |
US5824799A (en) | 1993-09-24 | 1998-10-20 | Biosite Diagnostics Incorporated | Hybrid phthalocyanine derivatives and their uses |
EP0687120A1 (de) * | 1994-06-09 | 1995-12-13 | ALCATEL BELL Naamloze Vennootschap | Reglementierungsverfahren zur Garantierung von fairem Durchsatz und Anlage zur Durchführung des Verfahrens |
US6991907B1 (en) * | 1995-04-18 | 2006-01-31 | Biosite, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
US6174686B1 (en) * | 1995-04-18 | 2001-01-16 | Biosite Diagnostics, Inc. | Methods for the assay of troponin I and T and complexes of troponin I and T and selection of antibodies for use in immunoassays |
US6627404B1 (en) * | 1995-04-18 | 2003-09-30 | Biosite, Inc. | Methods for improving the recovery of troponin I and T in membranes, filters and vessels |
US5795725A (en) | 1995-04-18 | 1998-08-18 | Biosite Diagnostics Incorporated | Methods for the assay of troponin I and T and selection of antibodies for use in immunoassays |
CA2248140C (en) * | 1996-03-04 | 2005-02-01 | Ronald P. Mischak | Assay and reagents for quantifying hbnp |
US5768163A (en) * | 1996-04-15 | 1998-06-16 | Hewlett-Packard | Versatile attachment of handheld devices to a host computing system |
US6113855A (en) | 1996-11-15 | 2000-09-05 | Biosite Diagnostics, Inc. | Devices comprising multiple capillarity inducing surfaces |
US6156521A (en) | 1997-12-19 | 2000-12-05 | Biosite Diagnostics, Inc. | Methods for the recovery and measurement of troponin complexes |
US5947124A (en) | 1997-03-11 | 1999-09-07 | Biosite Diagnostics Incorporated | Diagnostic for determining the time of a heart attack |
WO1999013331A1 (fr) * | 1997-09-11 | 1999-03-18 | Shionogi & Co., Ltd. | Procede de dosage immunologique pour bnp |
US6117644A (en) | 1998-06-04 | 2000-09-12 | Ottawa Heart Institute Research Corporation | Predicting and detecting cardiac allograft rejection |
US6171870B1 (en) * | 1998-08-06 | 2001-01-09 | Spectral Diagnostics, Inc. | Analytical test device and method for use in medical diagnoses |
US6309888B1 (en) | 1998-09-04 | 2001-10-30 | Leuven Research & Development Vzw | Detection and determination of the stages of coronary artery disease |
DE19847690A1 (de) | 1998-10-15 | 2000-04-20 | Brahms Diagnostica Gmbh | Verfahren und Substanzen für die Diagnose und Therapie von Sepsis und sepsisähnlichen systemischen Infektionen |
US6743595B1 (en) * | 1999-01-25 | 2004-06-01 | Metriogene Biosciences Inc. | Method and diagnostic kit for diagnosis of endometriosis |
US6670138B2 (en) | 2000-11-01 | 2003-12-30 | Agy Therapeutics, Inc. | Method of diagnosing ischemic stroke via UCP-2 detection |
US7524635B2 (en) * | 2003-04-17 | 2009-04-28 | Biosite Incorporated | Methods and compositions for measuring natriuretic peptides and uses thereof |
US20030199000A1 (en) * | 2001-08-20 | 2003-10-23 | Valkirs Gunars E. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US20040253637A1 (en) * | 2001-04-13 | 2004-12-16 | Biosite Incorporated | Markers for differential diagnosis and methods of use thereof |
US7713705B2 (en) * | 2002-12-24 | 2010-05-11 | Biosite, Inc. | Markers for differential diagnosis and methods of use thereof |
US20030219734A1 (en) * | 2001-04-13 | 2003-11-27 | Biosite Incorporated | Polypeptides related to natriuretic peptides and methods of their identification and use |
US20040203083A1 (en) * | 2001-04-13 | 2004-10-14 | Biosite, Inc. | Use of thrombus precursor protein and monocyte chemoattractant protein as diagnostic and prognostic indicators in vascular diseases |
US20040126767A1 (en) * | 2002-12-27 | 2004-07-01 | Biosite Incorporated | Method and system for disease detection using marker combinations |
US20040121350A1 (en) * | 2002-12-24 | 2004-06-24 | Biosite Incorporated | System and method for identifying a panel of indicators |
US20040176914A1 (en) * | 2001-04-13 | 2004-09-09 | Biosite Incorporated | Methods and compositions for measuring biologically active natriuretic peptides and for improving their therapeutic potential |
US7632647B2 (en) * | 2001-04-13 | 2009-12-15 | Biosite Incorporated | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes |
EP1666881B1 (de) * | 2001-05-04 | 2010-02-17 | Biosite Incorporated | Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen |
US6627457B2 (en) | 2001-07-30 | 2003-09-30 | Quest Diagnostics Investments Incorporated | Methods for detecting pregnancy |
US20040219509A1 (en) * | 2001-08-20 | 2004-11-04 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
JP2005522669A (ja) * | 2001-08-20 | 2005-07-28 | バイオサイト インコーポレイテッド | 卒中および脳損傷の診断マーカーおよびその使用方法 |
US20040209307A1 (en) * | 2001-08-20 | 2004-10-21 | Biosite Incorporated | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US7608406B2 (en) * | 2001-08-20 | 2009-10-27 | Biosite, Inc. | Diagnostic markers of stroke and cerebral injury and methods of use thereof |
US6461828B1 (en) | 2001-09-04 | 2002-10-08 | Syn X Pharma | Conjunctive analysis of biological marker expression for diagnosing organ failure |
JP2006527190A (ja) * | 2003-04-17 | 2006-11-30 | サイファージェン バイオシステムズ インコーポレイテッド | ナトリウム利尿ペプチドに関連したポリペプチド、並びにこれらの同定および使用法 |
US20060105419A1 (en) * | 2004-08-16 | 2006-05-18 | Biosite, Inc. | Use of a glutathione peroxidase 1 as a marker in cardiovascular conditions |
US20060051825A1 (en) * | 2004-09-09 | 2006-03-09 | Buechler Kenneth F | Methods and compositions for measuring canine BNP and uses thereof |
US7879979B2 (en) * | 2005-01-21 | 2011-02-01 | Alere International | Arginine analogs, and methods for their synthesis and use |
US20070269836A1 (en) * | 2005-06-09 | 2007-11-22 | Mcpherson Paul H | Methods and compositions for the diagnosis of venous thromboembolic disease |
WO2007028070A2 (en) * | 2005-08-30 | 2007-03-08 | Biosite, Inc. | Use of soluble flt-1 and its fragments in cardiovascular conditions |
EP2005168A4 (de) * | 2006-03-09 | 2009-05-20 | Biosite Inc | Verfahren und zusammensetzung zur diagnose von krankheiten der aorta |
US20080118924A1 (en) * | 2006-05-26 | 2008-05-22 | Buechler Kenneth F | Use of natriuretic peptides as diagnostic and prognostic indicators in vascular diseases |
US8524462B2 (en) * | 2006-11-14 | 2013-09-03 | Alere San Diego, Inc. | Methods and compositions for diagnosis and prognosis of renal artery stenosis |
EP2500723B1 (de) * | 2006-11-14 | 2015-07-08 | Alere San Diego, Inc. | Verfahren zur Überwachung und Risikoabschätzung des Herz-Nieren-Syndroms |
-
2001
- 2001-04-13 US US09/835,298 patent/US7632647B2/en active Active
-
2002
- 2002-04-11 ES ES02721720T patent/ES2310590T3/es not_active Expired - Lifetime
- 2002-04-11 NZ NZ523210A patent/NZ523210A/en not_active IP Right Cessation
- 2002-04-11 CA CA002412648A patent/CA2412648C/en not_active Expired - Lifetime
- 2002-04-11 AU AU2002252636A patent/AU2002252636B2/en not_active Ceased
- 2002-04-11 EP EP08160527.1A patent/EP1983058B1/de not_active Expired - Lifetime
- 2002-04-11 AT AT02721720T patent/ATE402266T1/de not_active IP Right Cessation
- 2002-04-11 DE DE60227763T patent/DE60227763D1/de not_active Expired - Lifetime
- 2002-04-11 WO PCT/US2002/011441 patent/WO2002083913A1/en active IP Right Grant
- 2002-04-11 EP EP02721720A patent/EP1311701B1/de not_active Revoked
- 2002-04-11 DK DK02721720T patent/DK1311701T3/da active
- 2002-04-11 JP JP2002582250A patent/JP3749225B2/ja not_active Expired - Lifetime
-
2003
- 2003-03-13 US US10/389,720 patent/US20040171064A1/en not_active Abandoned
-
2004
- 2004-08-18 JP JP2004238278A patent/JP4119408B2/ja not_active Expired - Fee Related
-
2007
- 2007-03-19 AU AU2007201180A patent/AU2007201180B2/en not_active Ceased
-
2010
- 2010-09-02 US US12/874,859 patent/US20110065210A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US7632647B2 (en) | 2009-12-15 |
US20110065210A1 (en) | 2011-03-17 |
AU2007201180B2 (en) | 2010-11-25 |
DK1311701T3 (da) | 2008-11-03 |
US20040171064A1 (en) | 2004-09-02 |
US20030022235A1 (en) | 2003-01-30 |
AU2007201180A1 (en) | 2007-04-19 |
JP3749225B2 (ja) | 2006-02-22 |
WO2002083913A1 (en) | 2002-10-24 |
EP1311701A1 (de) | 2003-05-21 |
CA2412648A1 (en) | 2002-10-24 |
EP1311701A4 (de) | 2005-11-09 |
NZ523210A (en) | 2007-04-27 |
EP1311701B1 (de) | 2008-07-23 |
CA2412648C (en) | 2008-10-21 |
ES2310590T3 (es) | 2009-01-16 |
JP2005049351A (ja) | 2005-02-24 |
JP2004519688A (ja) | 2004-07-02 |
EP1983058B1 (de) | 2013-12-18 |
AU2002252636B2 (en) | 2007-03-08 |
JP4119408B2 (ja) | 2008-07-16 |
EP1983058A1 (de) | 2008-10-22 |
ATE402266T1 (de) | 2008-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60227763D1 (de) | Verwendung eines natriuretischen peptids vom b-typ als prognostischer indikator bei akuten koronaren syndromen | |
Pacher et al. | Prognostic impact of big endothelin-1 plasma concentrations compared with invasive hemodynamic evaluation in severe heart failure | |
DE60235416D1 (de) | Diagnostische Marker der akuten koronaren Syndrome und ihre Verwendungen | |
EP1363128B8 (de) | Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern | |
WO2003078962A3 (en) | Detection and quantification of modified proteins | |
RU2003106971A (ru) | Способ оценки качества тестирующей полоски, устройство и считываемый компьютером носитель | |
AU2002252636A1 (en) | Use of B-type natriuretic peptide as a prognostic indicator in acute coronary syndromes | |
ATE449961T1 (de) | Elektrochemischer teststreifen zur verwendung bei der analyten-bestimmung | |
CA2315186A1 (en) | Methods for the recovery and measurement of troponin complexes | |
ATE382148T1 (de) | Antikörper für apoptosemarker und anwendungsverfahren | |
DE60129314D1 (de) | Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen | |
IL134565A0 (en) | Methods for the high-resolution identification of solvent-accessible amide hydrogens in polypeptides | |
PT1173770E (pt) | Metodo para estimar o risco de ulcera peptica | |
Kim et al. | Prediction of long-term mortality based on neutrophil-lymphocyte ratio after percutaneous coronary intervention | |
ATE182366T1 (de) | Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte | |
DK1664769T3 (da) | Assay til detektion af prohormoner for atrialt natriuretisk peptid og natriuretisk peptid i hjernen | |
DK1791973T3 (da) | DOT1-histonmethyltransferaser som et target til at identificere terapeutiske midler mod leukæmi | |
AU6415000A (en) | Indicator peptide for diagnosing and/or predicting cardiovascular and/or endothelial diseases, antibody composition and immunoassay | |
EP2071338A3 (de) | Menschliche Diabetes-vermittelnde Proteine | |
DE60332479D1 (de) | Holo-transcobalamin bindungspartner und ihre verwendung in cobalamintest | |
WO2002067766A8 (en) | Methods and material for evaluating cardiovascular conditions | |
DE60236203D1 (de) | Prüfverfahren für schreibgeräte | |
ATE432364T1 (de) | Sonden zum nachweis von tumorzellen | |
Zhu et al. | Diagnostic accuracy of brain natriuretic peptide and N-terminal-pro brain natriuretic peptide to detect complications of cardiac transplantation in adults: A systematic review and meta-analysis | |
RU2003108463A (ru) | Способ прогнозирования течения острого деструктивного панкреатита |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8363 | Opposition against the patent | ||
8328 | Change in the person/name/address of the agent |
Representative=s name: KOCH & SCHIWECK PATENTANWAELTE, 80339 MUENCHEN |